Risk of Metachronous Advanced Colorectal Neoplasia After Removal of Diminutive Versus Small Nonadvanced Adenomas: A Multicenter Study
Authors:
- Chi-Liang ChengCCChi-Liang Cheng
- Shuo-Wei ChenSCShuo-Wei Chen
- I-Chia SuISI-Chia Su
- Chi-Huang WuCWChi-Huang Wu
- Yen-Lin KuoYKYen-Lin Kuo
- Tsuo-Hsuan ChienTCTsuo-Hsuan Chien
- Yuh-Ying LiuYLYuh-Ying Liu
- Kuang-Chen HuangKHKuang-Chen Huang
- Cheng-Han XieCXCheng-Han Xie
- Mu-Hsien LeeMLMu-Hsien Lee
- Jui-Hsiang TangJTJui-Hsiang Tang
- Yi-Ning TsuiYTYi-Ning Tsui
- 5 July 2022
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (1) , 259-267
Abstract
Background Current postpolypectomy guidelines treat 1–9 mm nonadvanced adenomas (NAAs) as carrying the same level of risk for metachronous advanced colorectal neoplasia (ACRN). Aims To evaluate whether small (6–9 mm) NAAs are associated with a greater risk of metachronous ACRN than diminutive (1–5 mm) NAAs. Methods We retrospectively evaluated 10,060 index colonoscopies performed from July 2011 to June 2019. A total of 1369 patients aged ≥ 40 years with index NAAs and having follow-up examinations were categorized into 5 groups based on size and number of index findings: Group 1, ≤ 2 diminutive NAAs (n = 655); Group 2, ≤ 2 small NAAs (n = 529); Group 3, 3–4 diminutive NAAs (n = 78); Group 4, 3–4 small NAAs (n = 65); and Group 5, 5–10 NAAs (n = 42). Size was classified based on the largest NAA. ACRN was defined as finding an advanced adenoma or colorectal cancer at follow-up. Results The absolute risk of metachronous ACRN increased from 7.2% in patients with all diminutive NAAs to 12.2% in patients with at least 1 small NAA (P = 0.002). Patients in Group 2 (adjusted odds ratio [AOR] 1.89; 95% confidence interval [CI], 1.21–2.95), Group 3 (AOR 2.40; 95% CI 1.78–4.90), Group 4 (AOR 2.77; 95% CI 1.35–5.66), and Group 5 (AOR 3.71; 95% CI 1.65–8.37) were associated with an increased risk of metachronous ACRN compared with Group 1. Conclusions Patients with small NAAs have an increased risk of metachronous ACRN. Postpolypectomy guidelines should consider including risk stratification between small and diminutive adenomas.Keywords
This publication has 36 references indexed in Scilit:
- Endoscopic Mis-sizing of Polyps Changes Colorectal Cancer Surveillance RecommendationsDiseases of the Colon & Rectum, 2013
- Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer DeathsNew England Journal of Medicine, 2012
- Quality Indicators for Colonoscopy and the Risk of Interval CancerNew England Journal of Medicine, 2010
- A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studiesObesity Reviews, 2009
- Smoking and Colorectal CancerJAMA, 2008
- Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer SocietyGastroenterology, 2006
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- A Prospective Study of Family History and the Risk of Colorectal CancerNew England Journal of Medicine, 1994
- Prevention of Colorectal Cancer by Colonoscopic PolypectomyNew England Journal of Medicine, 1993
- Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous PolypsNew England Journal of Medicine, 1993